SCHEDULE 13G/AAccepted Feb 17, 6:55 PM ET
4D Molecular Therapeutics, Inc. SCHEDULE 13G/A
Accepted (ET)
6:55 PM
Feb 17, 2026
Filed
Feb 17, 2026
Documents
1
Size
7.6 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.